NO895087D0 - Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater.Info
- Publication number
- NO895087D0 NO895087D0 NO895087A NO895087A NO895087D0 NO 895087 D0 NO895087 D0 NO 895087D0 NO 895087 A NO895087 A NO 895087A NO 895087 A NO895087 A NO 895087A NO 895087 D0 NO895087 D0 NO 895087D0
- Authority
- NO
- Norway
- Prior art keywords
- eter
- derivatives
- procedure
- preparation
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88403311 | 1988-12-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO895087D0 true NO895087D0 (no) | 1989-12-18 |
| NO895087L NO895087L (no) | 1990-06-25 |
Family
ID=8200452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89895087A NO895087L (no) | 1988-12-23 | 1989-12-18 | Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5098932A (no) |
| EP (1) | EP0375457B1 (no) |
| JP (1) | JPH03135976A (no) |
| AU (1) | AU622965B2 (no) |
| CA (1) | CA2006095A1 (no) |
| DE (1) | DE68913940T2 (no) |
| DK (1) | DK665089A (no) |
| ES (1) | ES2063149T3 (no) |
| FI (1) | FI896015A7 (no) |
| GB (1) | GB8927287D0 (no) |
| HU (1) | HUT52494A (no) |
| IE (1) | IE63211B1 (no) |
| IL (1) | IL92580A (no) |
| NO (1) | NO895087L (no) |
| NZ (1) | NZ231666A (no) |
| PT (1) | PT92701A (no) |
| ZA (1) | ZA899688B (no) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE902113A1 (en) * | 1989-07-18 | 1991-06-19 | Ici Plc | Diaryl ether cyclic ethers |
| US5254581A (en) * | 1990-06-21 | 1993-10-19 | Imperial Chemical Industries Plc | Pyran derivatives and their use as inhibitors of 5-lipoxygenase |
| IE914005A1 (en) * | 1990-12-14 | 1992-06-17 | Zeneca Ltd | Novel intermediates |
| CA2058254A1 (en) * | 1991-01-15 | 1992-07-16 | John Francis Kingston | Benzodioxole derivatives |
| IL100483A0 (en) * | 1991-01-17 | 1992-09-06 | Ici Plc | Sulphonamide derivatives |
| US5258399A (en) * | 1991-01-17 | 1993-11-02 | Imperial Chemical Industries Plc | Sulphonamide derivatives |
| EP0505122A1 (en) * | 1991-03-21 | 1992-09-23 | Zeneca Limited | Alpha, alpha-dialkylbenzyl derivatives |
| DE69206725T2 (de) * | 1991-09-10 | 1996-05-02 | Zeneca Ltd | Benzolsulfonamidderivate als 5-Lipoxygenasehemmer |
| GB9300894D0 (en) * | 1992-02-07 | 1993-03-10 | Zeneca Ltd | Oxime derivatives |
| EP0555067A1 (en) * | 1992-02-07 | 1993-08-11 | Zeneca Limited | Hydroxylamine derivatives as 5-lipoxygenase inhibitors |
| CA2094465A1 (en) * | 1992-04-23 | 1993-10-24 | Pierre Andre Raymond Bruneau | Cycloalkane derivatives |
| CA2095006A1 (en) * | 1992-05-12 | 1993-11-13 | Philip Neil Edwards | Oxime derivatives |
| CA2095005A1 (en) * | 1992-05-12 | 1993-11-13 | Philip Neil Edwards | Hydroxylamine derivatives |
| US5231197A (en) * | 1992-06-01 | 1993-07-27 | General Electric Company | Method for producing ethylenically unsaturated graftable orthoesters |
| DE4228201A1 (de) * | 1992-08-25 | 1994-03-03 | Schering Ag | Neue Leukotrien-B¶4¶-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| AU4444393A (en) * | 1992-09-01 | 1994-03-10 | Zeneca Limited | Pyrrolidine derivatives |
| WO1994005638A1 (en) * | 1992-09-02 | 1994-03-17 | Abbott Laboratories | Trans 1,4-diether cyclohexane inhibitors of 5-lipoxygenase |
| US5446062A (en) * | 1993-11-12 | 1995-08-29 | Abbott Laboratories | ((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and arylalkynyl)urea inhibitors of 5-lipoxygenase |
| US5407959A (en) * | 1993-11-12 | 1995-04-18 | Abbott Laboratories | (Trans-1,4-dialkoxycyclohexyl) substituted arylalkylaryl-arylalkenylaryl-, and arylalkynylarylurea inhibitors of 5-lipoxygenase |
| US6515014B2 (en) | 1995-06-02 | 2003-02-04 | G. D. Searle & Co. | Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| WO1996038418A1 (en) | 1995-06-02 | 1996-12-05 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| US5643933A (en) * | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| US6512121B2 (en) | 1998-09-14 | 2003-01-28 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| US6136839A (en) * | 1995-06-12 | 2000-10-24 | G. D. Searle & Co. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| DE69709069T2 (de) | 1996-02-13 | 2002-07-04 | G.D. Searle & Co., Chicago | Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten |
| DK0880363T3 (da) | 1996-02-13 | 2003-01-20 | Searle & Co | Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger |
| US6677364B2 (en) * | 1998-04-20 | 2004-01-13 | G.D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| WO2002028182A1 (en) * | 2000-10-03 | 2002-04-11 | Syngenta Participations Ag | Phenylpropynyloxypyridine herbicides |
| GB2459809A (en) | 2007-02-22 | 2009-11-11 | Children S Hospital And Res Ct | Fatty acid formulations and methods of use thereof |
| CA3016289A1 (en) | 2016-03-03 | 2017-09-08 | Universite De Moncton | Modulators of lipoxygenase and cyclooxygenase enzyme activity |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3743737A (en) * | 1970-05-21 | 1973-07-03 | Smith Kline French Lab | 3-sulfonamido-4-hydroxyphenyl-2-piperindinylcarbinol compositions |
| US3661917A (en) * | 1970-05-21 | 1972-05-09 | Smith Kline French Lab | 3-sulfonamido-4-hydroxyphenyl-2-piperidylcarbinols |
| CA960676A (en) * | 1970-05-21 | 1975-01-07 | Smith Kline And French Canada Ltd. | 3-sulfonamido-4-hydroxyphenyl-2-piperidinylcarbinols |
| IE56702B1 (en) * | 1982-12-01 | 1991-11-06 | Usv Pharma Corp | Antiinflammatory antiallergic compounds |
| NZ213986A (en) * | 1984-10-30 | 1989-07-27 | Usv Pharma Corp | Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such |
| US4625034A (en) * | 1985-02-04 | 1986-11-25 | Usv Pharmaceutical Corp. | 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives |
| US4839369A (en) * | 1985-04-16 | 1989-06-13 | Rorer Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4876346A (en) * | 1985-05-02 | 1989-10-24 | American Home Products Corporation | Quinoline compounds |
| EP0271287A3 (en) * | 1986-12-11 | 1990-06-13 | Merck Frosst Canada Inc. | Quinoline dioic acids and amides |
| US4920130A (en) * | 1987-11-02 | 1990-04-24 | Rorer Pharamceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| US4920133A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| US4920131A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| US4918081A (en) * | 1988-06-20 | 1990-04-17 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene d4 |
| EP0349062A1 (en) * | 1988-06-27 | 1990-01-03 | Merck Frosst Canada Inc. | Quinoline ether alkanoic acid |
-
1989
- 1989-12-01 GB GB898927287A patent/GB8927287D0/en active Pending
- 1989-12-05 IE IE388189A patent/IE63211B1/en not_active IP Right Cessation
- 1989-12-06 IL IL9258089A patent/IL92580A/xx not_active IP Right Cessation
- 1989-12-07 NZ NZ231666A patent/NZ231666A/en unknown
- 1989-12-15 HU HU896627A patent/HUT52494A/hu unknown
- 1989-12-15 FI FI896015A patent/FI896015A7/fi not_active Application Discontinuation
- 1989-12-18 NO NO89895087A patent/NO895087L/no unknown
- 1989-12-18 ZA ZA899688A patent/ZA899688B/xx unknown
- 1989-12-20 CA CA002006095A patent/CA2006095A1/en not_active Abandoned
- 1989-12-21 AU AU47147/89A patent/AU622965B2/en not_active Ceased
- 1989-12-22 ES ES89313521T patent/ES2063149T3/es not_active Expired - Lifetime
- 1989-12-22 EP EP89313521A patent/EP0375457B1/en not_active Expired - Lifetime
- 1989-12-22 DE DE68913940T patent/DE68913940T2/de not_active Expired - Fee Related
- 1989-12-22 US US07/454,911 patent/US5098932A/en not_active Expired - Fee Related
- 1989-12-22 DK DK665089A patent/DK665089A/da not_active Application Discontinuation
- 1989-12-22 PT PT92701A patent/PT92701A/pt not_active Application Discontinuation
- 1989-12-25 JP JP1333011A patent/JPH03135976A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NO895087L (no) | 1990-06-25 |
| CA2006095A1 (en) | 1990-06-23 |
| DK665089D0 (da) | 1989-12-22 |
| NZ231666A (en) | 1992-01-29 |
| EP0375457A3 (en) | 1991-01-09 |
| AU622965B2 (en) | 1992-04-30 |
| DE68913940D1 (de) | 1994-04-21 |
| DE68913940T2 (de) | 1994-07-14 |
| IL92580A0 (en) | 1990-08-31 |
| US5098932A (en) | 1992-03-24 |
| AU4714789A (en) | 1990-06-28 |
| IE63211B1 (en) | 1995-04-05 |
| JPH03135976A (ja) | 1991-06-10 |
| PT92701A (pt) | 1990-06-29 |
| DK665089A (da) | 1990-06-24 |
| GB8927287D0 (en) | 1990-01-31 |
| EP0375457B1 (en) | 1994-03-16 |
| HUT52494A (en) | 1990-07-28 |
| IL92580A (en) | 1994-04-12 |
| EP0375457A2 (en) | 1990-06-27 |
| FI896015A7 (fi) | 1990-06-24 |
| ES2063149T3 (es) | 1995-01-01 |
| FI896015A0 (fi) | 1989-12-15 |
| ZA899688B (en) | 1990-08-29 |
| IE893881L (en) | 1990-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO895087L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater. | |
| NO894630D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO871266D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO904694L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO901684D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO870526D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO874032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO874153D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater. | |
| NO883122L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
| NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO893909L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO167739C (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive ginkolid-derivater. | |
| NO891114L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO864101L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO890607L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater. | |
| NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
| NO874780D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO890724D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. |